Concepedia

Scott Cooper

SC

Statistics

Publications

12

Citations

1.3K

H-Index

12

Active since

1996

Affiliations

Ionis Pharmaceuticals (United States)(Current)

University of South Alabama

Scott Cooper is an author at Ionis Pharmaceuticals (United States) specializing in pharmacology, life sciences, and molecular oncology.

Publications per year

1996–2012

12

Publications

12

An ICAM-1 Antisense Oligonucleotide Prevents and Reverses Dextran Sulfate Sodium-Induced Colitis in Mice

C. Frank Bennett, Doug Kornbrust, Scott P. Henry et al. · Journal of Pharmacology and Experimental Therapeutics · 1997 · 191 citations

Life Sciences, Immunology, Pathology +15

Folate-Liposome-Mediated Antisense Oligodeoxynucleotide Targeting to Cancer Cells: Evaluation in Vitro and in Vivo

Christopher P. Leamon, Scott Cooper, Gregory E. Hardee · Bioconjugate Chemistry · 2003 · 181 citations

Pharmacy, Oncology, Pharmacology +17

Inhibition of growth of human tumor cell lines in nude mice by an antisense of oligonucleotide inhibitor of protein kinase C-alpha expression.

Nicholas Dean, Robert A. McKay, Loren Miraglia et al. · PubMed · 1996 · 177 citations

Medicine, Oncology, Pharmacology +10

In Vivo Distribution and Metabolism of a Phosphorothioate Oligonucleotide within Rat Liver after Intravenous Administration

Mark Graham, Stanley T. Crooke, David Monteith et al. · Journal of Pharmacology and Experimental Therapeutics · 1998 · 139 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Antitumor Activity of Antisense Clusterin Oligonucleotides Is Improved in Vitro and in Vivo by Incorporation of 2′-O-(2-Methoxy)Ethyl Chemistry

Tobias Zellweger, H. Miyake, Scott Cooper et al. · Journal of Pharmacology and Experimental Therapeutics · 2001 · 132 citations

Medicine, Oncology, Pharmacology +14

1–5 of 12